Healthcare International Research

Healthcare International Research (HIR) is a healthcare and consumer wellness company based in Wimborne, England. Established in 2019, it develops cannabidiol (CBD) products with an emphasis on topical application rather than conventional orally ingested CBD oils. The company operates internationally, with reported markets including the United Kingdom, the European Union, South Africa, Saudi Arabia, Brazil, India, and the United States. HIR was founded by Farard Darver, a former British Army officer and commando. According to the available reference material, Darver turned to CBD after experiencing chronic pain associated with injuries sustained during his military service in Afghanistan. That personal experience shaped the company’s focus on CBD-based health, wellness, muscle-care, and skincare products. The company’s portfolio is organized around two consumer brands. HEMPE is positioned toward health and wellness, particularly products intended for joints, muscles, and pain relief. MotherSage is focused on beauty and skincare, including natural-beauty products such as lip balm. The reference material describes HIR’s CBD formulations as being developed with a scientifically oriented cannabinoid research company based in the Czech Republic, although the available information does not identify that partner by name. HIR has received external recognition for both of its principal brands. HEMPE won the Tatler Beauty Award for best product for joints and muscles in 2023. In 2024, the company received a UK Enterprise Award in the Best Sustainable Muscle & Skin Care Line category. MotherSage received the 2024 Green Parent Natural Beauty Award for Best Lip Balm, while HEMPE was recognized in the Global Excellence Awards as the Best CBD Pain Relief Brand in the United Kingdom for 2024. The company is privately held and no public ticker or exchange listing is identified in the available sources. A November 2023 reference described HIR as having an approximate valuation of £5 million and reported investment from British businessman Ian Prosser and Tim Youngman, a former director and partner of Ruffer Investment Company. Because the figure is presented as an approximate historical valuation rather than audited financial reporting, it should not be treated as a current market value. HIR’s business identity combines CBD research and formulation, topical healthcare and wellness products, and natural beauty branding.

Healthcare International Research was established in 2019 in Wimborne, England, by Farard Darver, a former British Army officer and commando. The company’s founding concept was connected to Darver’s experience of chronic pain following injuries sustained during military service in Afghanistan. The available account states that he found CBD oil helpful in managing that pain and subsequently developed a business centered on cannabinoid-based healthcare and wellness products. HIR differentiated its approach by concentrating on topical CBD applications instead of focusing primarily on orally consumed CBD oils. Its products were described as being formulated with the involvement of a scientifically based cannabinoid research company in the Czech Republic. The available reference does not identify the Czech research partner or provide detailed formulation, clinical, regulatory, or manufacturing information. The company built its commercial portfolio around two brands. HEMPE serves the health and wellness market, with particular emphasis on products associated with joints, muscles, and pain relief. MotherSage addresses beauty and skincare, extending HIR’s use of CBD and related natural-product positioning into personal care. This structure allows the company to present one brand around functional wellness and another around beauty and natural skincare. HIR reports an international operating footprint spanning the United Kingdom, the European Union, South Africa, Saudi Arabia, Brazil, India, and the United States. The available material does not specify the precise sales channels, local subsidiaries, distribution partners, or regulatory status in each market. It also does not identify a parent company, public listing, or current senior-management roster beyond the founder. The company gained public recognition through awards during 2023 and 2024. HEMPE received a Tatler Beauty Award for best product for joints and muscles in 2023. In 2024, HIR was recognized by the UK Enterprise Awards for Best Sustainable Muscle & Skin Care Line. MotherSage won the Green Parent Natural Beauty Award for Best Lip Balm, and HEMPE received a Global Excellence Award for Best CBD Pain Relief Brand in the United Kingdom. As of November 2023, the company was described in the reference material as having an approximate valuation of £5 million. The same account reported investment from Ian Prosser and Tim Youngman, the latter identified as a former director and partner of Ruffer Investment Company. No audited revenue, profit, funding round size, or current valuation is provided. HIR remains characterized in the available material as a privately held healthcare and consumer wellness business.

• 2024

  HIR and its brands receive multiple awards

  [1]Healthcare International Researchen.wikipedia.org

  HIR receives a UK Enterprise Award, MotherSage receives a Green Parent Natural Beauty Award, and HEMPE receives a Global Excellence Award for UK CBD pain relief.

• 2023

  HEMPE receives Tatler Beauty recognition

  [1]Healthcare International Researchen.wikipedia.org

  HEMPE receives the Tatler Beauty Award for the best product for joints and muscles.

• 2023

  Investment and valuation reported

  [1]Healthcare International Researchen.wikipedia.org

  By November 2023, reference material reports an approximate company valuation of £5 million and investment from Ian Prosser and Tim Youngman.

• 2019

  Healthcare International Research is founded

  [1]Healthcare International Researchen.wikipedia.org

  Farard Darver establishes Healthcare International Research in Wimborne, England, with a focus on cannabidiol-based healthcare and wellness products.

A research-oriented CBD healthcare and wellness company emphasizing topical formulations for muscle, joint, pain-relief, skincare, and natural-beauty applications.

• Health and wellness CBD brand

  HEMPE

  HEMPE is Healthcare International Research’s health and wellness brand. It emphasizes topical cannabidiol products associated with muscle care, joint care, and pain relief rather than positioning the portfolio primarily around orally ingested CBD oils. The brand received recognition for joints and muscles from Tatler in 2023 and for CBD pain relief in the United Kingdom from the Global Excellence Awards in 2024.

• CBD beauty and skincare brand

  MotherSage

  MotherSage is HIR’s beauty and skincare brand. It applies the company’s CBD and natural-product positioning to personal-care products, including lip balm. The brand was recognized in 2024 by the Green Parent Natural Beauty Awards in the Best Lip Balm category. Detailed product specifications and the full range are not identified in the available reference.

1. 1Healthcare International Researchen.wikipedia.org